Effects of Percutaneous Endoscopic Gastrostomy in Patients With Huntington Disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 25, 2020
- Accepted March 19, 2021
- First Published April 16, 2021.
Article Versions
- Previous version (April 16, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Emma Frank (emma.frank{at}uvm.edu),
- Allison Dyke, BS (allisondyke{at}gmail.com),
- Sarah MacKenzie, MS, CCC-SLP, CBIS (smackenz{at}bidmc.harvard.edu),
- Evagelia Maskwa, RD, LDN, CNSC (emaskwa{at}bidmc.harvard.edu) and
- Samuel Frank, MD
- Emma Frank (emma.frank{at}uvm.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Allison Dyke, BS (allisondyke{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sarah MacKenzie, MS, CCC-SLP, CBIS (smackenz{at}bidmc.harvard.edu),
NONE
NONE
(1) Harvard Medical School, speaker honoraria
NONE
NONE
NONE
(1) Beth Israel Deaconess Medical Center, SLP III, 2016- 2021 (2) Spaulding Rehabilitation Hospital, SLP, 2012-2021 (3) Emerson College - Speech@Emerson graduate program, course facilitator, 2020-2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Evagelia Maskwa, RD, LDN, CNSC (emaskwa{at}bidmc.harvard.edu) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Samuel Frank, MD
I serve as the Chair of the DSMB for KINECT-HD, a Huntington Study Group study funded by Neurocrine biosciences.
NONE
NONE
Associate Editor of Journal of Huntington Disease
NONE
NONE
NONE
Sage Therapeutics, Skyhawk Pharmaceuticals, Oscine Therapeutics, uniQure
NONE
NONE
NONE
Roche/Genentech, Huntington Study Group/Vaccinex, Triplet Therapeutics
NONE
NONE
CHDI Foundation, Huntington's Disease Society of America
NONE
NONE
NONE
NONE
NONE
NONE
- University of Vermont (EF), Burlington, VT; University of New Hampshire (AD), Manchester, NH; and Beth Israel Deaconess Medical Center (SM, EM, SF), Boston, MA.
- Correspondence
Dr. S. Frank sfrank2{at}bidmc.harvard.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.